BioResearch Monitors, Inc.


Quality assurance and regulatory compliance services for

pharmaceutical and biomedical research and development

Who We Are

BioResearch Monitors, Inc.

Established in 1992 provides professional, cost-effective quality auditing, and consulting services related to FDA, ICH, ISO and related worldwide quality standards for good clinical practices (GCP), good manufacturing practices (GMP), good laboratory practices (GLP) and related quality standards for pharmaceutical research and development.


BioResearch Monitors, Inc. is a consulting group specializing in Quality Assurance and Regulatory Compliance assessments of Pharmaceutical and related Biomedical Research and Development activities. Gary T Sniffen,  the President of BioResearch Monitors, Inc. has been involved in managing, conducting and establishing standards for Worldwide Research Quality Assurance since 1981. Our Quality Assurance and Clinical Research Associates are all highly qualified professionals with significant industry, medical and/or government (FDA) experience.


BioResearch Monitors, Inc. conducts audits and evaluations which assess the quality and integrity of research data; evaluate compliance with U.S. and multi-national regulatory obligations pertaining to Sponsors, Monitors, Clinical Investigators & Institutional Review Boards; and document that studies were audited by an independent Quality Assurance group.


26 Johns Drive
Pennellville, NY 13132
Ph: 315.668.6043 Fax: 315.668.8368


Why Us

 BioResearch Monitors is dedicated to providing the highest Quality regulatory compliance, auditing, and training options.  

We will do everything we can to understand your needs and meet your expectations.  Look around our website and if you have any questions, please contact us.


Gary Sniffen has over 30 years experience in Quality Assurance of clinical pharmaceutical research and development.  Prior to joining BioResearch Monitors, Inc., Mr. Sniffen was Senior Compliance Auditor, Worldwide Regulatory Compliance, Bristol-Myers Squibb Company, Pharmaceutical Research Institute. In his capacity, Mr. Sniffen planned, supervised and conducted Good Clinical Practices (GCP's) Quality Assurance/Regulatory Compliance evaluations of clinical trials.

Mr. Sniffen received a B.S. degree in Biology from LeMoyne College and a B.S. degree in Medical Technology from State University of New York, Upstate Medical Center (Health Science Center) in Syracuse N.Y. He is an Associate Member of the American Society of Clinical Pathologists (ASCP) and an ASCP registered Medical Technologist.

Mr. Sniffen has extensive experience in evaluating both domestic and multi-national clinical trials.